As with any other category of IRD, the selected treatment method for ABCA4-associated retinopathy may vary from mutation-specific techniques to more commonly used cell replacement, primarily dependent on the initial genetic abnormality and the stage of the disease at the beginning of therapy (Figure 4). The gene discussed is ABCA4; the disease is retinal disorder.